CINEDIGM NAMES TOM HASSELL VICE-PRESIDENT OF THEATRICAL DISTRIBUTION

on January 09, 2013
Print

Los Angeles, CA -- Cinedigm Digital Cinema Corp. (NASDAQ: CIDM) today announced Tom Hassell has been named Vice-President of Theatrical Distribution.

Hassell will be responsible for all aspects of theatrical distribution for Cinedigm, the leading strategic indie film and alternative content distributor that utilizes digital distribution and targeted marketing to cost-effectively release films. Some recent high profile theatrical acquisitions for Cinedigm include ARTHUR NEWMAN (with Colin Firth and Emily Blunt), VIOLET AND DAISY (with Saoirse Ronan and James Gandolfini) and the acclaimed documentary, THE INVISIBLE WAR.

Hassell's career in major motion picture distribution spans nearly three decades and is built upon experience with films ranging from the internationally commercial ("GHOSTBUSTERS") to the art-house specialized feature ("THE GIRL WITH THE DRAGON TATTO; "LA VIE EN ROSE") and includes positions at Columbia Pictures, Polygram Filmed Entertainment, Destination Films, New Market Films, Picturehouse Films, and Film District.

"Tom brings expertise, savvy and world-class business instincts to Cinedigm," said Susan Margolin, co-President of Cinedigm's entertainment group. "In the last year, we have made tremendous strides in our entertainment efforts, distributing films from five-screen targeted releases to 20-screen day-and-day releases to films spanning 1,000 screens - and we have many more projects slated for 2013. Tom will play a critical role in releasing these films in the ‘Cinedigm' way - putting producers first, being good partners to the exhibition community and bringing compelling content to demanding audiences."

"I am very excited about joining such a forward-looking company of smart and innovative people," said Hassell. "I look forward to being part of what is, and will be, a compelling force in the changing landscape of the entertainment business."

 

Tags: CInedigm
Print

read all News »


Comments

No comments were posted.

What do you think?